Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Calidi Biotherapeutics Inc.
CLDICurrent price
1.11 USD
-0.045 USD (-3.91%)
Last closed
1.17 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Capitalization
9 377 614 USD
Yield for 12 month
-96.45 %
1Y
3Y
5Y
10Y
15Y
CLDI
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors. The company offers NeuroNova platform and SuperNova platform. The company is headquartered in San Diego, California. Address: 4475 Executive Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+45 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-1 256 000 USD
Last Year
-229 000 USD
Current Quarter
-378 000 USD
Last Quarter
-374 000 USD
Key Figures CLDI
1 year
3 years
5 years
10 years
EBITDA
-29 177 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-222.49 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
6.25 USD
Revenue TTM
–
Book Value
-1.82 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
31 000 USD
Earnings per share
-3.85 USD
Diluted Eps TTM
-3.85 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CLDI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLDI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
15.07.2024
Dividend Date
–
Stock Valuation CLDI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
49.4238
Price Sales TTM
50.8277
Enterprise Value EBITDA
-1.635
Price Book MRQ
–
Financials CLDI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CLDI
For 52 weeks
1.01 USD
42.5 USD
50 Day MA
1.48 USD
Shares Short Prior Month
590 378
200 Day MA
6.07 USD
Short Ratio
2.11
Shares Short
334 956
Short Percent
5.11 %
BeatStart